This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third view: Discussing VX-548, to be a first-in-class non-opioid treatment for acute pain in bunionectomy and abdominoplasty

Ticker(s): VRTX

Who's the expert?

Institution: US Anesthesia Partners

  • Board certified in Anesthesiology and Pain Medicine, in a full time clinical practice for 15 years.
  • manages about 20 bunionectomy and 5-10 abdominoplasty acute pain patients each month
  • reviewed the phase 2 study results for VX-548 on the company website

Interview Goal
To discuss VX-548 as a non-opioid treatment for acute pain in bunionectomy and abdominoplasty and the results from the Phase 2 proof-of-concept studies of VX-548.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.